An eczema treatment method comprises application of a therapeutically effective composition in the form of an aqueous
topical cream to an affected area of an exterior
skin region of a patient, the aqueous
topical cream comprising water, a water-soluble organic liquid, a surface
active agent, and
vitamin D3 compound or another claimed analog thereof, the
vitamin D3 compound or the analog constituting at least approximately 10 international units per
gram (IU /
gram), and, most preferably at least approximately 400 IU /
gram. An eczema treatment composition comprises a therapeutically effective formulation comprising at least approximately 50%-90% water, between approximately 1-5% PEG-40
stearate, between approximately 1-5% steareth-2, and cholecalciferal at a concentration of at least approximately 50 international units per gram (IU / g) of composition, and, most preferably at least approximately 400 IU / g. A topical
vitamin D cream for
therapeutic treatment of eczema includes vitamin D or an analog thereof chosen from the group consisting of
cholecalciferol,
alfacalcidol, calcifedol, and ergocalciferol; water; a water-soluble organic liquid; and a surface
active agent, the vitamin D or analog being in a concentration of at least approximately 50 international units per gram (IU / g) of cream. Remarkably, relief from eczema conditions occurs immediately or in less than 3 days.